Serveur d'exploration H2N2

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.

Identifieur interne : 000550 ( Main/Exploration ); précédent : 000549; suivant : 000551

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.

Auteurs : José Vicente Pérez-Gir N ; Sergio G Mez-Medina ; Anja Lüdtke ; Cesar Munoz-Fontela [Allemagne]

Source :

RBID : pubmed:26168339

Descripteurs français

English descriptors

Abstract

Vaccines are one of the greatest achievements of mankind, and have saved millions of lives over the last century. Paradoxically, little is known about the physiological mechanisms that mediate immune responses to vaccines perhaps due to the overall success of vaccination, which has reduced interest into the molecular and physiological mechanisms of vaccine immunity. However, several important human pathogens including influenza virus still pose a challenge for vaccination, and may benefit from immune-based strategies. Although influenza reverse genetics has been successfully applied to the generation of live-attenuated influenza vaccines (LAIVs), the addition of molecular tools in vaccine preparations such as tracer components to follow up the kinetics of vaccination in vivo, has not been addressed. In addition, the recent generation of mouse models that allow specific depletion of leukocytes during kinetic studies has opened a window of opportunity to understand the basic immune mechanisms underlying vaccine-elicited protection. Here, we describe how the combination of reverse genetics and chimeric mouse models may help to provide new insights into how vaccines work at physiological and molecular levels, using as example a recombinant, cold-adapted, live-attenuated influenza vaccine (LAIV). We utilized laboratory-generated LAIVs harboring cell tracers as well as competitive bone marrow chimeras (BMCs) to determine the early kinetics of vaccine immunity and the main physiological mechanisms responsible for the initiation of vaccine-specific adaptive immunity. In addition, we show how this technique may facilitate gene function studies in single animals during immune responses to vaccines. We propose that this technique can be applied to improve current prophylactic strategies against pathogens for which urgent medical countermeasures are needed, for example influenza, HIV, Plasmodium, and hemorrhagic fever viruses such as Ebola virus.

DOI: 10.3791/52803
PubMed: 26168339


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.</title>
<author>
<name sortKey="Perez Gir N, Jose Vicente" sort="Perez Gir N, Jose Vicente" uniqKey="Perez Gir N J" first="José Vicente" last="Pérez-Gir N">José Vicente Pérez-Gir N</name>
<affiliation>
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.</nlm:affiliation>
<wicri:noCountry code="subField">Leibniz Institute for Experimental Virology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="G Mez Medina, Sergio" sort="G Mez Medina, Sergio" uniqKey="G Mez Medina S" first="Sergio" last="G Mez-Medina">Sergio G Mez-Medina</name>
<affiliation>
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.</nlm:affiliation>
<wicri:noCountry code="subField">Leibniz Institute for Experimental Virology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ludtke, Anja" sort="Ludtke, Anja" uniqKey="Ludtke A" first="Anja" last="Lüdtke">Anja Lüdtke</name>
<affiliation>
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.</nlm:affiliation>
<wicri:noCountry code="subField">Leibniz Institute for Experimental Virology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Munoz Fontela, Cesar" sort="Munoz Fontela, Cesar" uniqKey="Munoz Fontela C" first="Cesar" last="Munoz-Fontela">Cesar Munoz-Fontela</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology; cesar.munoz-fontela@hpi.uni-hamburg.de.</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
<wicri:regionArea>Laboratory of Emerging Viruses, Heinrich Pette Institute</wicri:regionArea>
<wicri:noRegion>Heinrich Pette Institute</wicri:noRegion>
<wicri:noRegion>Heinrich Pette Institute</wicri:noRegion>
<wicri:noRegion>Heinrich Pette Institute</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26168339</idno>
<idno type="pmid">26168339</idno>
<idno type="doi">10.3791/52803</idno>
<idno type="wicri:Area/PubMed/Corpus">000070</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000070</idno>
<idno type="wicri:Area/PubMed/Curation">000070</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000070</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000067</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000067</idno>
<idno type="wicri:Area/Ncbi/Merge">000B92</idno>
<idno type="wicri:Area/Ncbi/Curation">000B92</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000B92</idno>
<idno type="wicri:Area/Main/Merge">000551</idno>
<idno type="wicri:Area/Main/Curation">000550</idno>
<idno type="wicri:Area/Main/Exploration">000550</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.</title>
<author>
<name sortKey="Perez Gir N, Jose Vicente" sort="Perez Gir N, Jose Vicente" uniqKey="Perez Gir N J" first="José Vicente" last="Pérez-Gir N">José Vicente Pérez-Gir N</name>
<affiliation>
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.</nlm:affiliation>
<wicri:noCountry code="subField">Leibniz Institute for Experimental Virology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="G Mez Medina, Sergio" sort="G Mez Medina, Sergio" uniqKey="G Mez Medina S" first="Sergio" last="G Mez-Medina">Sergio G Mez-Medina</name>
<affiliation>
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.</nlm:affiliation>
<wicri:noCountry code="subField">Leibniz Institute for Experimental Virology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Ludtke, Anja" sort="Ludtke, Anja" uniqKey="Ludtke A" first="Anja" last="Lüdtke">Anja Lüdtke</name>
<affiliation>
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology.</nlm:affiliation>
<wicri:noCountry code="subField">Leibniz Institute for Experimental Virology</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Munoz Fontela, Cesar" sort="Munoz Fontela, Cesar" uniqKey="Munoz Fontela C" first="Cesar" last="Munoz-Fontela">Cesar Munoz-Fontela</name>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Emerging Viruses, Heinrich Pette Institute, Leibniz Institute for Experimental Virology; cesar.munoz-fontela@hpi.uni-hamburg.de.</nlm:affiliation>
<country wicri:rule="url">Allemagne</country>
<wicri:regionArea>Laboratory of Emerging Viruses, Heinrich Pette Institute</wicri:regionArea>
<wicri:noRegion>Heinrich Pette Institute</wicri:noRegion>
<wicri:noRegion>Heinrich Pette Institute</wicri:noRegion>
<wicri:noRegion>Heinrich Pette Institute</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of visualized experiments : JoVE</title>
<idno type="eISSN">1940-087X</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Chimera</term>
<term>Dendritic Cells (immunology)</term>
<term>Female</term>
<term>HEK293 Cells</term>
<term>Humans</term>
<term>Immunity, Mucosal (drug effects)</term>
<term>Influenza A Virus, H1N1 Subtype (immunology)</term>
<term>Influenza A Virus, H2N2 Subtype (immunology)</term>
<term>Influenza Vaccines (administration & dosage)</term>
<term>Influenza Vaccines (genetics)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
<term>T-Lymphocytes (immunology)</term>
<term>Vaccines, Synthetic (administration & dosage)</term>
<term>Vaccines, Synthetic (genetics)</term>
<term>Vaccines, Synthetic (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules HEK293</term>
<term>Cellules dendritiques (immunologie)</term>
<term>Chimère</term>
<term>Femelle</term>
<term>Humains</term>
<term>Immunité muqueuse ()</term>
<term>Lymphocytes T (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
<term>Sous-type H1N1 du virus de la grippe A (immunologie)</term>
<term>Sous-type H2N2 du virus de la grippe A (immunologie)</term>
<term>Vaccins antigrippaux (administration et posologie)</term>
<term>Vaccins antigrippaux (génétique)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins synthétiques (administration et posologie)</term>
<term>Vaccins synthétiques (génétique)</term>
<term>Vaccins synthétiques (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en">
<term>Influenza Vaccines</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr">
<term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Immunity, Mucosal</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Influenza Vaccines</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cellules dendritiques</term>
<term>Lymphocytes T</term>
<term>Sous-type H1N1 du virus de la grippe A</term>
<term>Sous-type H2N2 du virus de la grippe A</term>
<term>Vaccins antigrippaux</term>
<term>Vaccins synthétiques</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Dendritic Cells</term>
<term>Influenza A Virus, H1N1 Subtype</term>
<term>Influenza A Virus, H2N2 Subtype</term>
<term>Influenza Vaccines</term>
<term>T-Lymphocytes</term>
<term>Vaccines, Synthetic</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Chimera</term>
<term>Female</term>
<term>HEK293 Cells</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Inbred C57BL</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Cellules HEK293</term>
<term>Chimère</term>
<term>Femelle</term>
<term>Humains</term>
<term>Immunité muqueuse</term>
<term>Souris</term>
<term>Souris de lignée C57BL</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Vaccines are one of the greatest achievements of mankind, and have saved millions of lives over the last century. Paradoxically, little is known about the physiological mechanisms that mediate immune responses to vaccines perhaps due to the overall success of vaccination, which has reduced interest into the molecular and physiological mechanisms of vaccine immunity. However, several important human pathogens including influenza virus still pose a challenge for vaccination, and may benefit from immune-based strategies. Although influenza reverse genetics has been successfully applied to the generation of live-attenuated influenza vaccines (LAIVs), the addition of molecular tools in vaccine preparations such as tracer components to follow up the kinetics of vaccination in vivo, has not been addressed. In addition, the recent generation of mouse models that allow specific depletion of leukocytes during kinetic studies has opened a window of opportunity to understand the basic immune mechanisms underlying vaccine-elicited protection. Here, we describe how the combination of reverse genetics and chimeric mouse models may help to provide new insights into how vaccines work at physiological and molecular levels, using as example a recombinant, cold-adapted, live-attenuated influenza vaccine (LAIV). We utilized laboratory-generated LAIVs harboring cell tracers as well as competitive bone marrow chimeras (BMCs) to determine the early kinetics of vaccine immunity and the main physiological mechanisms responsible for the initiation of vaccine-specific adaptive immunity. In addition, we show how this technique may facilitate gene function studies in single animals during immune responses to vaccines. We propose that this technique can be applied to improve current prophylactic strategies against pathogens for which urgent medical countermeasures are needed, for example influenza, HIV, Plasmodium, and hemorrhagic fever viruses such as Ebola virus. </div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="G Mez Medina, Sergio" sort="G Mez Medina, Sergio" uniqKey="G Mez Medina S" first="Sergio" last="G Mez-Medina">Sergio G Mez-Medina</name>
<name sortKey="Ludtke, Anja" sort="Ludtke, Anja" uniqKey="Ludtke A" first="Anja" last="Lüdtke">Anja Lüdtke</name>
<name sortKey="Perez Gir N, Jose Vicente" sort="Perez Gir N, Jose Vicente" uniqKey="Perez Gir N J" first="José Vicente" last="Pérez-Gir N">José Vicente Pérez-Gir N</name>
</noCountry>
<country name="Allemagne">
<noRegion>
<name sortKey="Munoz Fontela, Cesar" sort="Munoz Fontela, Cesar" uniqKey="Munoz Fontela C" first="Cesar" last="Munoz-Fontela">Cesar Munoz-Fontela</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000550 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000550 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:26168339
   |texte=   Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:26168339" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a H2N2V1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021